| |
| |
|
| Insider
Information: |
Alam John J |
| Relationship: |
CEO & President, Direc... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
866,331 |
|
|
Indirect Shares
|
737,179 |
|
|
| Direct
Value |
$60,586,888 |
|
|
|
Indirect Value
|
$2,397,132 |
|
|
| Total
Shares |
1,603,510 |
|
|
| Total
Value |
$62,984,020 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Med. Dev. Group &... |
2008-10-01 |
136,792 |
2008-10-01 |
5,140 |
Premium* |
|
|
Cervomed Ord Shs |
CRVO |
CEO & President, Direc... |
2023-11-09 |
729,539 |
2023-11-09 |
732,039 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRVO |
Cervomed Ord Shs |
CEO and PresidentOfficer |
• • • |
2023-08-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
742,039 |
|
- |
|
| CRVO |
Cervomed Ord Shs |
CEO and PresidentOfficer |
• • • |
2023-08-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
742,039 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Drug Eval. & Appr. |
• – – |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
19,454 |
|
- |
|
| CRVO |
Cervomed Ord Shs |
CEO & President |
• • • |
2023-11-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,500 |
729,539 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
• – – |
2007-11-16 |
4 |
AS |
$25.82 |
$26 |
D/D |
(1) |
119,324 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Drug Eval. & Appr. |
• – – |
2004-03-17 |
4 |
A |
$0.01 |
$38 |
D/D |
3,780 |
23,234 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Drug Eval. & Appr. |
• – – |
2005-02-03 |
4 |
A |
$0.01 |
$57 |
D/D |
5,700 |
93,934 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
• – – |
2008-02-07 |
4 |
A |
$0.01 |
$97 |
D/D |
9,667 |
128,511 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-02-02 |
4 |
A |
$0.01 |
$122 |
D/D |
12,200 |
103,856 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Product Dev. & CMO |
• – – |
2007-01-24 |
4 |
A |
$0.01 |
$321 |
D/D |
32,084 |
135,460 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Drug Eval. & Appr. |
• – – |
2004-05-06 |
4 |
A |
$0.01 |
$650 |
D/D |
65,000 |
88,234 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
• – – |
2008-05-21 |
4 |
AS |
$27.89 |
$2,231 |
D/D |
(80) |
128,511 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
• – – |
2007-12-11 |
4 |
AS |
$25.41 |
$12,298 |
D/D |
(480) |
118,844 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
• – – |
2008-05-20 |
4 |
AS |
$27.47 |
$19,918 |
D/D |
(722) |
128,591 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
• – – |
2006-11-29 |
4 |
OE |
$9.07 |
$23,005 |
D/D |
1,500 |
105,356 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
• – – |
2006-12-06 |
4 |
OE |
$9.07 |
$23,005 |
D/D |
1,500 |
105,356 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
• – – |
2006-12-13 |
4/A |
OE |
$9.07 |
$23,005 |
D/D |
1,500 |
105,356 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Drug Eval. & Appr. |
• – – |
2006-12-20 |
4 |
OE |
$9.07 |
$23,005 |
D/D |
1,500 |
104,876 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Drug Eval. & Appr. |
• – – |
2006-12-27 |
4 |
OE |
$9.07 |
$23,005 |
D/D |
1,500 |
104,876 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Drug Eval. & Appr. |
• – – |
2007-01-03 |
4 |
OE |
$9.07 |
$23,005 |
D/D |
1,500 |
104,876 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev., & CMO |
• – – |
2007-01-10 |
4 |
OE |
$9.07 |
$23,005 |
D/D |
1,500 |
104,876 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev., & CMO |
• – – |
2007-01-17 |
4 |
OE |
$9.07 |
$23,005 |
D/D |
1,500 |
104,876 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Product Dev. & CMO |
• – – |
2007-01-24 |
4 |
OE |
$9.07 |
$23,005 |
D/D |
1,500 |
136,960 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev., & CMO |
• – – |
2007-01-31 |
4 |
OE |
$9.07 |
$23,005 |
D/D |
1,500 |
136,960 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
• – – |
2007-05-17 |
4 |
AS |
$31.95 |
$25,368 |
D/D |
(794) |
119,324 |
0 |
- |
|
68 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
